Post-pandemic Era-Global Oncology Biosimilar Market Analysis 2024, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

Report ID: 256032 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Oncology Biosimilar Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Lung Cancer -Product Introduction and Major Manufacturers
      1.1.2 Colorectal Cancer -Product Introduction and Major Manufacturers
      1.1.3 Cervical Cancer -Product Introduction and Major Manufacturers
      1.1.4 Breast Cancer -Product Introduction and Major Manufacturers
      1.1.5 Kidney Cancer -Product Introduction and Major Manufacturers
      1.1.6 Stomach Cancer -Product Introduction and Major Manufacturers
      1.1.7 Brain Cancer -Product Introduction and Major Manufacturers
      1.1.8 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2019-2026)
    2.2 Regional Market Share in Terms of Revenue (2019-2026)
    2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Oncology Biosimilar Market Assessment by Type
    3.1 Global Oncology Biosimilar Production by Type (2015-2026)
    3.2 Global Oncology Biosimilar Revenue by Type (2015-2026)
    3.3 China Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.4 EU Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.5 USA Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.6 Japan Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.7 India Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.8 Southeast Asia Oncology Biosimilar Production and Revenue by Type (2015-2026)
    3.9 South America Oncology Biosimilar Production and Revenue by Type (2015-2026)

4 Global Oncology Biosimilar Market Assessment by Application
    4.1 Historical & Forecast Global Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.2 Historical & Forecast China Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.3 Historical & Forecast EU Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.4 Historical & Forecast USA Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.5 Historical & Forecast Japan Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.6 Historical & Forecast India Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.7 Historical & Forecast Southeast Asia Oncology Biosimilar Consumption, Different Application Field (2015-2026)
    4.8 Historical & Forecast South America Oncology Biosimilar Consumption, Different Application Field (2015-2026)

5 Global Oncology Biosimilar Average Price Trend
    5.1 Market Price for Each Type of Oncology Biosimilar in China (2015-2026)
    5.2 Market Price for Each Type of Oncology Biosimilar in EU (2015-2026)
    5.3 Market Price for Each Type of Oncology Biosimilar in USA (2015-2026)
    5.4 Market Price for Each Type of Oncology Biosimilar in Japan (2015-2026)
    5.5 Market Price for Each Type of Oncology Biosimilar in India (2015-2026)
    5.6 Market Price for Each Type of Oncology Biosimilar in Southeast Asia (2015-2026)
    5.7 Market Price for Each Type of Oncology Biosimilar in South America (2015-2026)
6 Value Chain (Impact of COVID-19)
    6.1 Oncology Biosimilar Value Chain Analysis
      6.1.1 Upstream
      6.1.2 Downstream
    6.2 COVID-19 Impact on Oncology Biosimilar Industry
      6.2.1 Industrial Policy Issued Under the Epidemic Situation
    6.3 Cost-Under the Epidemic Situation
      6.3.1 Cost of Raw Material
    6.4 Channel Analysis
      6.4.1 Distribution Channel-Under the Epidemic Situation
      6.4.2 Distributors

7 Oncology Biosimilar Competitive Analysis
     7.1 Biocon
        7.1.1 Biocon Company Profiles
        7.1.2 Biocon Product Introduction
        7.1.3 Biocon Oncology Biosimilar Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Celltrion Inc.
        7.2.1 Celltrion Inc. Company Profiles
        7.2.2 Celltrion Inc. Product Introduction
        7.2.3 Celltrion Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Dr. Reddy's Laboratories
        7.3.1 Dr. Reddy's Laboratories Company Profiles
        7.3.2 Dr. Reddy's Laboratories Product Introduction
        7.3.3 Dr. Reddy's Laboratories Oncology Biosimilar Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Intas Pharmaceuticals Ltd.
        7.4.1 Intas Pharmaceuticals Ltd. Company Profiles
        7.4.2 Intas Pharmaceuticals Ltd. Product Introduction
        7.4.3 Intas Pharmaceuticals Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 STADA Arzneimittel AG
        7.5.1 STADA Arzneimittel AG Company Profiles
        7.5.2 STADA Arzneimittel AG Product Introduction
        7.5.3 STADA Arzneimittel AG Oncology Biosimilar Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Pfizer Inc.
        7.6.1 Pfizer Inc. Company Profiles
        7.6.2 Pfizer Inc. Product Introduction
        7.6.3 Pfizer Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Apotex Inc.
        7.7.1 Apotex Inc. Company Profiles
        7.7.2 Apotex Inc. Product Introduction
        7.7.3 Apotex Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Teva Pharmaceutical Industries Ltd.
        7.8.1 Teva Pharmaceutical Industries Ltd. Company Profiles
        7.8.2 Teva Pharmaceutical Industries Ltd. Product Introduction
        7.8.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 Sandoz International GmbH
        7.9.1 Sandoz International GmbH Company Profiles
        7.9.2 Sandoz International GmbH Product Introduction
        7.9.3 Sandoz International GmbH Oncology Biosimilar Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 BIOCAD
        7.10.1 BIOCAD Company Profiles
        7.10.2 BIOCAD Product Introduction
        7.10.3 BIOCAD Oncology Biosimilar Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
     7.11 Mylan
     7.12 F Hoffmann-La Roche
8 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Oncology Biosimilar Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table Regional Market Share in Terms of Production (2019-2026)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2019-2026)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure Global Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Production Market Share (%) by Type (2019 -2020)
    Table Global Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure Global Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Revenue Market Share (%) by Type (2019-2020)
    Figure China Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure China Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure China Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure China Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure EU Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure EU Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure EU Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure EU Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure USA Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure USA Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure USA Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure USA Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Japan Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure Japan Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure Japan Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure Japan Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure India Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure India Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure India Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure India Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Figure South America Oncology Biosimilar Production (K Unit) by Type (2015-2026)
    Figure South America Oncology Biosimilar Production (K Unit) and Growth Rate (2015-2026)
    Figure South America Oncology Biosimilar Revenue (Million USD) by Type (2015-2026)
    Figure South America Oncology Biosimilar Revenue (Million USD) and Growth Rate (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure China Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure China Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure EU Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure EU Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure USA Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure USA Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure Japan Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Japan Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure India Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure India Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure Southeast Asia Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Figure South America Oncology Biosimilar Consumption (K Unit) and Growth Rate (2015-2026)
    Figure South America Oncology Biosimilar Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Oncology Biosimilar Different Application Field Consumption (K Unit)
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in China
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in EU
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in USA
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in Japan
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in India
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Oncology Biosimilar in South America
    Figure Value Chain Structure of Oncology Biosimilar
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Oncology Biosimilar
    Figure Cost Structure of Oncology Biosimilar in 2020
    Table Distributors/Traders List
    Table Biocon Profiles
    Table Biocon Oncology Biosimilar Product Introduction
    Figure Biocon Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Biocon SWOT Analysis
    Table Celltrion Inc. Profiles
    Table Celltrion Inc. Oncology Biosimilar Product Introduction
    Figure Celltrion Inc. Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Celltrion Inc. SWOT Analysis
    Table Dr. Reddy's Laboratories Profiles
    Table Dr. Reddy's Laboratories Oncology Biosimilar Product Introduction
    Figure Dr. Reddy's Laboratories Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Dr. Reddy's Laboratories SWOT Analysis
    Table Intas Pharmaceuticals Ltd. Profiles
    Table Intas Pharmaceuticals Ltd. Oncology Biosimilar Product Introduction
    Figure Intas Pharmaceuticals Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Intas Pharmaceuticals Ltd. SWOT Analysis
    Table STADA Arzneimittel AG Profiles
    Table STADA Arzneimittel AG Oncology Biosimilar Product Introduction
    Figure STADA Arzneimittel AG Chemical & Material Production, Revenue (2015-2020)
    Figure STADA Arzneimittel AG SWOT Analysis
    Table Pfizer Inc. Profiles
    Table Pfizer Inc. Oncology Biosimilar Product Introduction
    Figure Pfizer Inc. Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Pfizer Inc. SWOT Analysis
    Table Apotex Inc. Profiles
    Table Apotex Inc. Oncology Biosimilar Product Introduction
    Figure Apotex Inc. Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Apotex Inc. SWOT Analysis
    Table Teva Pharmaceutical Industries Ltd. Profiles
    Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Product Introduction
    Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Teva Pharmaceutical Industries Ltd. SWOT Analysis
    Table Sandoz International GmbH Profiles
    Table Sandoz International GmbH Oncology Biosimilar Product Introduction
    Figure Sandoz International GmbH Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Sandoz International GmbH SWOT Analysis
    Table BIOCAD Profiles
    Table BIOCAD Oncology Biosimilar Product Introduction
    Figure BIOCAD Oncology Biosimilar Production, Revenue (2015-2020)
    Figure BIOCAD SWOT Analysis
    Table Mylan Profiles
    Table Mylan Oncology Biosimilar Product Introduction
    Figure Mylan Oncology Biosimilar Production, Revenue (2015-2020)
    Figure Mylan SWOT Analysis
    Table F Hoffmann-La Roche Profiles
    Table F Hoffmann-La Roche Oncology Biosimilar Product Introduction
    Figure F Hoffmann-La Roche Oncology Biosimilar Production, Revenue (2015-2020)
    Figure F Hoffmann-La Roche SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Oncology Biosimilar Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Oncology Biosimilar Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Oncology Biosimilar Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports